Pfizer and BioNTech’s clinical trial to evaluate their COVID-19 vaccine in pregnant women has been discontinued, according to a newly disclosed internal Pfizer email filed as evidence in a recent court case. The case in part questions whether the vaccine has been adequately tested to assess for risks to women’s reproductive health.
A professor of medicine at the University of Calgary sent an email on April 1 to Pfizer Canada inquiring about the status of the clinical trial, which was announced publicly in February 2021.
